Is Leap Therapeutics Inc (LPTX) Holding Up Well Over a Long-Time Horizon?

Leap Therapeutics Inc [LPTX] stock prices are up 9.28% to $0.40 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The LPTX shares have gain 3.82% over the last week, with a monthly amount glided 5.86%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Leap Therapeutics Inc [NASDAQ: LPTX] stock has seen the most recent analyst activity on January 29, 2025, when Robert W. Baird downgraded its rating to a Neutral and also revised its price target to $1.25 from $9. Previously, H.C. Wainwright downgraded its rating to Neutral on January 29, 2025. On June 28, 2024, Rodman & Renshaw initiated with a Buy rating and assigned a price target of $8 on the stock. Mizuho started tracking the stock assigning a Buy rating and suggested a price target of $6 on October 04, 2021. Piper Sandler started tracking with a Overweight rating for this stock on June 29, 2020, and assigned it a price target of $6. In a note dated February 11, 2020, Robert W. Baird initiated an Outperform rating and provided a target price of $6 on this stock.

The stock price of Leap Therapeutics Inc [LPTX] has been fluctuating between $0.22 and $4.79 over the past year. Currently, Wall Street analysts expect the stock to reach $5.5 within the next 12 months. Leap Therapeutics Inc [NASDAQ: LPTX] shares were valued at $0.40 at the most recent close of the market. An investor can expect a potential return of 1275.0% based on the average LPTX price forecast.

Analyzing the LPTX fundamentals

To continue investigating profitability, this company’s Return on Assets is posted at -1.98, Equity is -1.62 and Total Capital is -3.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.

Ratios To Look Out For

It’s worth pointing out that Leap Therapeutics Inc [NASDAQ:LPTX]’s Current Ratio is 2.41. On the other hand, the Quick Ratio is 2.41, and the Cash Ratio is 2.33.

Related Posts

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.